<DOC>
	<DOCNO>NCT02485080</DOCNO>
	<brief_summary>The goal pilot study examine efficacy tolerability patient HCV genotype 1 mild decompensation Child-Pugh-Turcott score 6 low . The CPT score use assess prognosis chronic liver disease , well required strength treatment necessity liver transplantation . A high CPT score denote high necessity liver transplantation .</brief_summary>
	<brief_title>Safety , Tolerability , Efficacy 24 Weeks Simeprevir+Sofosbuvir Chronic Hepatitis C Genotype 1</brief_title>
	<detailed_description>Key objective study include : 1 . To describe efficacy ( SVR ) special population patient chronic hepatitis C willing candidate IFN-based therapy . 2 . To describe safety , tolerability , treatment persistency patient population advance liver disease .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Simeprevir</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Inclusion criterion : 1 . Adult 1872 year 2 . Cirrhosis : define stage 4 biopsy noninvasive test presence splenomegaly platelet 130K low , presence shrink nodular liver CT MRI , presence varix encephalopathy ascites . 3 . HCV genotype 1 indeterminate later assess Screening confirm genotype 1 Exclusion criterion : 1 . Uncontrolled ascites , uncontrolled hepatic encephalopathy , uncontrolled esophageal/gastric varix 2 . Coinfection HIV hepatitis B ( HBV ) 3 . CPT 7 , MELD &gt; 10 4 . Total bilirubin 4.0 mg/dL 5 . CrCl ( creatinine clearance ) &lt; 30 mL/min 6 . Any unstable active medical illness . 7 . Active use illicit substance , alcohol , smoking . 8 . Any malignancy within last 5 year except basal cell skin cancer adequately treat HCC within Milan UCSF criterion , acceptable 9 . Any prior treatment direct acting antiviral ( approved investigational ) , include HCV protease inhibitor , SMV . Patients receive prior treatment SOF , and/or NS5A inhibitor ( e.g . ledipasvir Daclatasvir ) include study 10 . Platelet &lt; 30 K/uL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>hepatitis C</keyword>
	<keyword>liver transplantation</keyword>
	<keyword>genotype 1</keyword>
</DOC>